Frank Hölzle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Frank Hölzle has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Klaus-Dietrich Wolff
Department of Oral and Maxillofacial Surgery, University Hospital "Klinikum rechts der Isar", München, Germany
2 shared publications - Stefan Wagenpfeil
Affiliation Institute for Medical Biometry, Epidemiology and Medical Informatics, Saarland University, Homburg/Saar, Germany
2 shared publications - Bettina Hohlweg-Majert
Department of Oral and Maxillofacial Surgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
1 shared publication Craig J. Wales
Department of Oral and Maxillofacial Surgery, Southern General Hospital, Glasgow, Scotland
1 shared publication- Denys John Loeffelbein
Department of Oral and Maxillofacial Surgery, Technische Universität München, Germany
1 shared publication Dirk Nolte
1 shared publication
Latest Publications
- 16 February 2011
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 40 (8) , 598-603
Expression of host defence peptides in the lip vermilion mucosa during early infancy
Emerging resistance to antibiotics has become a major problem. Host defence peptides (HDPs), which are effector molecules of the innate immune system, show broad antimicrobial activity. Synthetic derivates are currently being investigated as new anti-infectious agents. In infants, the use of conventional antibiotics is limited to a few substances because of adverse reactions. The new HDP substances might become alternatives to conventional antibiotics, but knowledge of the physiological quantities of the HDPs in infants is essential because of a narrow therapeutic index of currently available derivates. This study compares the mRNA levels of five major HDPs between infants and adults to test the hypothesis that HDP gene expression differs between these groups. Expression profiles of human beta-defensin (hBD)-1, hBD-2 and hBD-3, psoriasin and RNase 7 were assessed in the lip vermilion mucosa of infants (n = 15) and adult controls (n = 15) using real-time polymerase chain reaction. A significantly lower expression of hBD-2 (P = 0.043), hBD-3 (P = 0.014) and psoriasin (P = 0.018) was found in infants. No difference between the groups was noted with respect to transcript levels of hBD-1 and RNase 7. In conclusion, several HDPs are expressed at lower levels in infants, but not all. The results emphasize the need to adjust the dose of agents based on the specific HDP level for the treatment of infantile infections.
- 16 February 2011
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 40 (8) , 598-603
Expression of host defence peptides in the lip vermilion mucosa during early infancy
Emerging resistance to antibiotics has become a major problem. Host defence peptides (HDPs), which are effector molecules of the innate immune system, show broad antimicrobial activity. Synthetic derivates are currently being investigated as new anti-infectious agents. In infants, the use of conventional antibiotics is limited to a few substances because of adverse reactions. The new HDP substances might become alternatives to conventional antibiotics, but knowledge of the physiological quantities of the HDPs in infants is essential because of a narrow therapeutic index of currently available derivates. This study compares the mRNA levels of five major HDPs between infants and adults to test the hypothesis that HDP gene expression differs between these groups. Expression profiles of human beta-defensin (hBD)-1, hBD-2 and hBD-3, psoriasin and RNase 7 were assessed in the lip vermilion mucosa of infants (n = 15) and adult controls (n = 15) using real-time polymerase chain reaction. A significantly lower expression of hBD-2 (P = 0.043), hBD-3 (P = 0.014) and psoriasin (P = 0.018) was found in infants. No difference between the groups was noted with respect to transcript levels of hBD-1 and RNase 7. In conclusion, several HDPs are expressed at lower levels in infants, but not all. The results emphasize the need to adjust the dose of agents based on the specific HDP level for the treatment of infantile infections.
- 1 February 2010
- Vol. 41 (2) , 165-71
Content of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in oral mucosa and inflamed periodontal tissue.
Recent literature has demonstrated that local proteolytic enzymes participate in periodontitis and peri-implantitis. The aim of the present study was to evaluate whether the serine proteases urokinase-type plasminogen activator (uPA) and its plasminogen activator inhibitor type 1 (PAI-1) show elevated amounts in inflamed periodontal tissues as compared to healthy oral mucosa to determine if these proteins are involved in the process of periodontal breakdown. Fifty-eight patients with severe periodontitis were included in this study. Periodontal therapy was performed by means of modified Widman flaps. During surgery, samples of healthy oral mucosa and inflamed tissues were taken. Highly sensitive ELISAs allowed for determination of uPA and PAI-1 content in inflamed periodontal tissues and healthy oral mucosa. The amount of uPA and PAI-1 in diseased periodontal tissue was significantly higher than in the clinically healthy oral mucosa (P=or<.002). However, no statistically significant correlation with the sex or age of the patients or attachment loss of the teeth was seen. Serine proteases uPA and its inhibitor PAI-1 participate in periodontitis.
- 1 February 2010
- Vol. 41 (2) , 165-71
Content of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in oral mucosa and inflamed periodontal tissue.
Recent literature has demonstrated that local proteolytic enzymes participate in periodontitis and peri-implantitis. The aim of the present study was to evaluate whether the serine proteases urokinase-type plasminogen activator (uPA) and its plasminogen activator inhibitor type 1 (PAI-1) show elevated amounts in inflamed periodontal tissues as compared to healthy oral mucosa to determine if these proteins are involved in the process of periodontal breakdown. Fifty-eight patients with severe periodontitis were included in this study. Periodontal therapy was performed by means of modified Widman flaps. During surgery, samples of healthy oral mucosa and inflamed tissues were taken. Highly sensitive ELISAs allowed for determination of uPA and PAI-1 content in inflamed periodontal tissues and healthy oral mucosa. The amount of uPA and PAI-1 in diseased periodontal tissue was significantly higher than in the clinically healthy oral mucosa (P=or<.002). However, no statistically significant correlation with the sex or age of the patients or attachment loss of the teeth was seen. Serine proteases uPA and its inhibitor PAI-1 participate in periodontitis.
- 1 January 2003
- Published by Wiley in Microsurgery
- Vol. 23 (4) , 306-312
Nutritive perfusion at donor site after microvascular fibula transfer
There are many reports on the versatility of the fibular flap, but only a few studies have reported on the morbidity, and none on the nutritive perfusion, of the donor site. This study describes for the first time the quantitative investigation of nutritive perfusion at the donor site after osteomyo‐cutaneous fibula transfer. Tissue nutrition of the lower leg was measured in 25 patients by micro‐lightguide spectrophotometry and laser Doppler flowmetry. In a standardized examination, hemoglobin oxygenation and blood flow of the donor leg and the contralateral leg (intraindividual control) were measured at the nutritive region of the peroneal artery (I), posterior tibial artery (II), and anterior tibial artery (III). In the operated leg, blood flow was significantly reduced in region I with the sacrificed peroneal artery, and significantly increased in region II and III, probably for compensation (P = 0.03). Decreased hemoglobin oxygenation and blood flow of the peroneal region at the donor site were without significance in comparison to the control leg (P = 0.55 and P = 0.35, respectively). Decreased nutritive perfusion at the donor site was below the threshold of clinical manifestation, and supports the low donor site morbidity following fibular grafting. © 2003 Wiley‐Liss, Inc. MICROSURGERY 23:306–312 2003
- 1 January 2003
- Published by Wiley in Microsurgery
- Vol. 23 (4) , 306-312
Nutritive perfusion at donor site after microvascular fibula transfer
There are many reports on the versatility of the fibular flap, but only a few studies have reported on the morbidity, and none on the nutritive perfusion, of the donor site. This study describes for the first time the quantitative investigation of nutritive perfusion at the donor site after osteomyo‐cutaneous fibula transfer. Tissue nutrition of the lower leg was measured in 25 patients by micro‐lightguide spectrophotometry and laser Doppler flowmetry. In a standardized examination, hemoglobin oxygenation and blood flow of the donor leg and the contralateral leg (intraindividual control) were measured at the nutritive region of the peroneal artery (I), posterior tibial artery (II), and anterior tibial artery (III). In the operated leg, blood flow was significantly reduced in region I with the sacrificed peroneal artery, and significantly increased in region II and III, probably for compensation (P = 0.03). Decreased hemoglobin oxygenation and blood flow of the peroneal region at the donor site were without significance in comparison to the control leg (P = 0.55 and P = 0.35, respectively). Decreased nutritive perfusion at the donor site was below the threshold of clinical manifestation, and supports the low donor site morbidity following fibular grafting. © 2003 Wiley‐Liss, Inc. MICROSURGERY 23:306–312 2003